NPC VIDEO

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is... Watch Video

RECENT NEWS

Blog Post

CER Tweets of the Week: Improving Patient Care Remains Hot Topic (July 14 - 18)

Evidence-based medicine (EBM) and the role of big data in improving patient care continued to be hot topics... more
Blog Post

CER Tweets of the Week: Patient-Generated Data, Value-Based Payment Programs & Impact of CER (July 7 - 11)

Which issues attracted comparative effectiveness research (CER) stakeholders’ attention this week in the ... more
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
Blog Post

CER Tweets of the Week: Evidence-Based Medicine & #PCORI Advisory Panels (June 30th – July 4th)

What was trending among comparative effectiveness research (CER) stakeholders on Twitter this week? Dialogue... more
Newsletter Subpage

PCORI Makes Appointments to Advisory Panels, Announces More Funding for Pragmatic Studies

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors met on June 17 to address a number... more
Newsletter Subpage

Earn CE Credits Via CER Collaborative’s Certificate Program on Evaluating Research Findings

Formulary decision-makers are aware that comparative effectiveness research (CER) has the potential for positive... more
Newsletter Subpage

Employers Still Trying to Find Right Strategy for Specialty Drug Benefits, According to Latest MBGH Survey

While almost 75% of employers incentivize for employee use of a specialty pharmacy, there are minimal or no... more
Newsletter Subpage

Researchers Explore Challenges in Health Technology Assessment at June Meeting in DC

Health care researchers from around the world gathered in Washington, DC, this month for the Health Technology... more
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty... more
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use... more
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important... more
Press Release

NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies

(Washington, DC, February 25, 2014)—With the growing demand for information about comparative effectiveness and... more
Commentary and Testimony Page

Healthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data

March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... more
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... more
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... more
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... more
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology... more
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health... more
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study... more
Blog Post

CER Tweets of the Week: Improving Patient Care Remains Hot Topic (July 14 - 18)

Evidence-based medicine (EBM) and the role of big data in improving patient care continued to be hot topics... more
Blog Post

CER Tweets of the Week: Patient-Generated Data, Value-Based Payment Programs & Impact of CER (July 7 - 11)

Which issues attracted comparative effectiveness research (CER) stakeholders’ attention this week in the ... more
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
Blog Post

CER Tweets of the Week: Evidence-Based Medicine & #PCORI Advisory Panels (June 30th – July 4th)

What was trending among comparative effectiveness research (CER) stakeholders on Twitter this week? Dialogue... more

WEBINAR

Consumer-Directed Health Plans: Pharmacy Benefits & Best Practices

NPC will share survey results of 96 large and jumbo employers about their current benefit practices, and the best practices developed based on the results.

July 23, 2014
1 pm – 2 pm ET


Learn More

NEWS

CER Is Important, But Impact Is Still on the Horizon

“The survey provides an important look at how perceptions of CER have shifted during the implementation of the Affordable Care Act.” —NPC Director of Health Services Research Kimberly Westrich